Login
Register
Submit a Paper
Propose a Special lssue
Open Access
RETRACTION
Retraction: lncRNA FEZF1-AS1 Is Associated with Prognosis in Lung Adenocarcinoma and Promotes Cell Proliferation, Migration, and Invasion
Oncology Research 2025, 33(5), 1251-1252. https://doi.org/10.32604/or.2025.065346
Issue published 18 April 2025
This article is a retraction of:
lncRNA FEZF1-AS1 Is Associated With Prognosis in Lung Adenocarcinoma and Promotes Cell Proliferation, Migration, and Invasion
Read original article
View Full Text
Download PDFAbstract
This article has no abstract.Cite This Article
APA Style
Oncology Research Editorial Office (2025). Retraction: lncRNA FEZF1-AS1 Is Associated with Prognosis in Lung Adenocarcinoma and Promotes Cell Proliferation, Migration, and Invasion. Oncology Research, 33(5), 1251–1252. https://doi.org/10.32604/or.2025.065346
Vancouver Style
Oncology Research Editorial Office. Retraction: lncRNA FEZF1-AS1 Is Associated with Prognosis in Lung Adenocarcinoma and Promotes Cell Proliferation, Migration, and Invasion. Oncol Res. 2025;33(5):1251–1252. https://doi.org/10.32604/or.2025.065346
IEEE Style
Oncology Research Editorial Office, “Retraction: lncRNA FEZF1-AS1 Is Associated with Prognosis in Lung Adenocarcinoma and Promotes Cell Proliferation, Migration, and Invasion,” Oncol. Res., vol. 33, no. 5, pp. 1251–1252, 2025. https://doi.org/10.32604/or.2025.065346
Copyright © 2025 The Author(s). Published by Tech Science Press.This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Downloads
Citation Tools
